Effect of self-efficacy and social support on adherence to antihypertensive drugs.
OBJECTIVE
To determine the relationship between poor adherence and self-efficacy or social support after a pharmacist intervention.


METHODS
Post-hoc analysis of data from two randomized controlled trials of physician-pharmacist collaborative interventions (6 and 9 mo, respectively) to improve blood pressure control.


METHODS
Eleven university-affiliated primary care clinics.


METHODS
Five hundred eighty-four patients (aged 21-85 yrs) with uncontrolled primary hypertension; 296 were in the intervention group and 288 were in the control group.


METHODS
Pharmacists provided intensified hypertension management and drug adherence counseling to patients in the intervention group.


RESULTS
Social support and self-efficacy questionnaires were administered at baseline and end-of-study visits. Patient adherence was monitored by using the Morisky self-reported adherence questionnaire. Self-reported adherence scores improved significantly in the control group (p=0.0053) but not in the intervention group; however, adherence at baseline in both groups was high. There were small, but significant, improvements in self-efficacy (p<0.04) and social support (p<0.05) scores in the intervention group but not the control group at the end of the study. Social support and, to a lesser extent, self-efficacy improved as a function of duration of study participation (9-mo vs 6-mo intervention), regardless of whether the patient received the intervention. Blood pressure control in both groups improved significantly at the end of the study; however, mean blood pressure was significantly lower in the intervention group (129.7/76.6 mm Hg) compared with the control group (140.8/78.9 mm Hg; p<0.0001 for systolic, p=0.032 for diastolic).


CONCLUSIONS
Social support and self-efficacy improved significantly in the intervention group at the end of the pharmacist intervention. Drug adherence was correlated with self-efficacy even though drug adherence did not improve significantly in the intervention group. The fact that social support and self-efficacy improved as a function of duration of study participation suggests that participation in a research study may have had a positive influence on these measures. Even though the changes in social support, self-efficacy, and drug adherence were modest, there was significantly better blood pressure control in the intervention group compared with the control group. These findings indicate that changes in drug adherence, self-efficacy, or social support probably played a minor role in the blood pressure outcomes in these studies.
Criswell
Thomas J
TJ
Department of Pharmacy Practice and Science, College of Pharmacy, University of Iowa, Iowa City, Iowa 52242, USA.
Weber
Cynthia A
CA
Xu
Yinghui
Y
Carter
Barry L
BL
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D003299:Cooperative Behavior; D004502:Education, Medical, Continuing; D015987:Effect Modifier, Epidemiologic; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D055118:Medication Adherence / Q000523:psychology*; D008875:Middle Aged; D010593:Pharmaceutical Services; D010595:Pharmacists; D010820:Physicians; D017410:Practice Guidelines as Topic; D020377:Self Efficacy; D012944:Social Support; D013223:Statistics as Topic; D011795:Surveys and Questionnaires; D013997:Time Factors; D055815:Young Adult
D000959:Antihypertensive Agents
Pharmacotherapy. 2000 Aug;20(8):941-9
10939555
Circulation. 2008 Jun 24;117(25):e510-26
18574054
Pharmacotherapy. 2001 Aug;21(8):940-53
11718500
Clin Ther. 2002 Aug;24(8):1347-57; discussion 1346
12240784
Am J Health Syst Pharm. 2009 Apr 1;66(7):657-64
19299373
J Hypertens Suppl. 1986 Dec;4(6):S14-7
3302149
JAMA. 2002 Dec 18;288(23):2981-97
12479763
JAMA. 2003 May 21;289(19):2560-72
12748199
J Gen Intern Med. 2007 Jun;22(6):768-74
17364243
JAMA. 2002 Nov 20;288(19):2421-31
12435255
Am J Hypertens. 2005 May;18(5 Pt 1):619-26
15882544
Hypertension. 2005 Jan;45(1):142-61
15611362
J Hum Hypertens. 2002 Jun;16(6):439-44
12037702
Pharmacotherapy. 2010 Mar;30(3):228-35
20180606
JAMA. 2006 Dec 6;296(21):2563-71
17101639
Pharm World Sci. 2008 Jan;30(1):128-35
17710561
J Clin Hypertens (Greenwich). 2008 Jan;10(1 Suppl 1):20-6
18174780
Hypertension. 2004 Nov;44(5):602-8
15381676
Health Educ Q. 1985 Spring;12(1):35-50
3980239
Arch Intern Med. 2009 Nov 23;169(21):1996-2002
19933962
Hypertension. 2003 Dec;42(6):1206-52
14656957
J Clin Hypertens (Greenwich). 2008 Apr;10(4):260-71
18401223
Arch Intern Med. 2009 Oct 26;169(19):1748-55
19858431
MedGenMed. 2007 Sep 19;9(3):58
18092064
J Fam Pract. 1983 Nov;17(5):837-41
6355370
J Pers Soc Psychol. 1982 Jul;43(1):5-21
7108745
Ethn Dis. 2004 Winter;14(1):3-12
15002917
J Abnorm Psychol. 1974 Feb;83(1):56-64
4855861
Pharmacotherapy. 2008 Sep;28(9):1104-14
18752381
J Adv Nurs. 1994 Feb;19(2):233-8
8188953
J Clin Hypertens (Greenwich). 2008 May;10(5):348-54
18453793
Ann Pharmacother. 2009 Mar;43(3):413-22
19261962
J Clin Epidemiol. 2003 Jun;56(6):520-9
12873646
Med Care. 1986 Jan;24(1):67-74
3945130